Stratec SE (ETR:SBS – Get Free Report)’s share price traded down 0.2% during mid-day trading on Friday . The stock traded as low as €22.45 and last traded at €22.45. 1,155 shares traded hands during trading, a decline of 82% from the average session volume of 6,253 shares. The stock had previously closed at €22.50.
Stratec Trading Down 0.2%
The company has a market cap of $269.71 million, a price-to-earnings ratio of 26.94, a PEG ratio of 10.43 and a beta of 0.16. The company has a current ratio of 2.52, a quick ratio of 1.65 and a debt-to-equity ratio of 66.97. The business’s 50 day moving average price is €22.21 and its 200-day moving average price is €25.63.
About Stratec
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
Featured Stories
- Five stocks we like better than Stratec
- 3 Overlooked Deductions to Help Potentially Minimize Capital Gains Tax
- The Crash Has Already Started (Most Just Don’t See It Yet)
- A U.S. “birthright” claim worth trillions – activated quietly
- But this $2 Gold Stock Before May 20, 2026
- Jeff Brown’s Prediction: Banks Replacing Dollars Soon
Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.
